Jupiter Neurosciences FY26 Q2 net loss widens 0.95% to $2.27 million; revenue totals $24,245

Reuters2026/08/14 20:49

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Jupiter Neurosciences posted a Q2 net loss of $2.27 million, widening slightly from a year earlier; loss per share improved to $4.08.
Revenue totaled $24,245, up from no revenue a year earlier; operating loss widened to $2.74 million.
R&D expense fell 21% to $600,353, while G&A climbed 44% to $2.16 million due to higher payroll and consulting costs.
Other income rose to $468,548 on a $549,098 gain from marking convertible notes to market; interest expense jumped to $90,618.
Pharmaceutical pipeline advanced with an FDA-cleared Parkinson’s Phase IIa trial starting in Q2; Nugevia supplement sales began shipping in Q4 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-038463), on August 14, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Goldman Sachs Asia-Pacific Chief Equity Strategist Timothy Moe maintains a KOSPI target of 12,000 points, implying an almost 80% increase from the current level. He points out that the market is systematically underestimating the sustainability of the AI storage chip profit cycle. Capital expenditures by US tech giants may exceed $1.2 trillion next year, and the chip shortage triggered by data center expansion will further intensify in 2027. The current KOSPI is trading at only 5.3 times expected earnings, about half of its historical average.

华尔街见闻•2026/09/07 01:26

Norwegian sovereign wealth fund may cut $80 billion US Treasury holdings; high-rated mortgage securities expected to become new favorites

Norway's sovereign wealth fund, with a scale of $2.3 trillions, has recommended reducing government bond holdings and reallocating funds towards higher-yielding fixed income assets.

智通财经•2026/09/07 01:21